Curierul Medical, 2016, Vol. 59, No 5

Curierul medical. October 2016, Vol. 59, No 5

2021-09-08T12:06:25Z

Curierul medical. October 2016, Vol. 59, No 5 From its debut in 1958, the journal has striven to support the interests of Moldovan medicine concerning the new concepts of its development. The Editorial Board warmly welcomes both the readers of and the authors for the journal, all those who are enthusiastic in searching the new and more effective ways of solving numerous medical problems. We hope that those who want to make their contribution into the science of medicine will find our journal helpful and encouraging. The journal is accredited by the National Council for Accreditation and Attestation. The journal publishes official papers, scientific articles, editorials, clinical studies and cases, lectures, methodological guides, reviews, brief reports, and correspondence. The journal welcomes articles in English, Romanian and Russian. The journal editorial policy provides the prompt publication of papers within 12 weeks after receiving them.; De la prima apariţie în 1958, revista susţine şi dezvoltă noile idei în domeniul medicinii, în Republica Moldova. Colegiul de redacţie agrează cu multă consideraţie atât cititorii cât şi autorii articolelor, pe toţi acei care cu mult entuziasm caută noi şi mult mai efective metode de soluţionare a multiplelor probleme ale medicinii. Sperăm, că toţi acei care doresc să-şi aducă aportul la dezvoltarea ştiinţelor medicale, vor găsi revista noastră utilă şi atractivă. Revista este acreditată de către Consiliul Naţional de Acreditare și Atestare. Revista publică comunicări oficiale și, totodată, sunt editate diverse publicaţii, inclusiv independente: articole știinţifice, editoriale, cercetări și prezentări de cazuri clinice, prelegeri, îndrumări metodice, articole de sinteză, relatări scurte, corespondenţe și recenzii. Revista publică articole în limba engleză, română și rusă. Politica de editare a revistei prevede examinarea operativă și publicarea articolelor timp de 12 săptămâni după înaintare.; С первого дня своего выпуска в 1958 году журнал стремится поддерживать и развивать новые идеи в области медицины в Молдове. Редакционная коллегия всегда рада как читателям, так и авторам статей, всем тем, кто с энтузиазмом ищет новые, более эффективные способы решения многочисленных задач медицины. Мы надеемся, что все те, кто хотят внести свой вклад в медицинскую науку, найдут наш журнал полезным и вдохновляющим. Журнал аккредитован Высшей Аттестационной Комиссией Республики Молдова. В журнале печатаются официальные материалы, научные статьи, наблюдения из клинической практики, обобщающие статьи, краткие сообщения, методические указания, рецензии и корреспонденция. В журнале публикуются статьи на английском, румынском и русском языках. Издательская политика журнала предусматривает оперативное рассмотрение и публикацию статей в среднем в течение 12 недель после поступления. Fondatori: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”

Illarion Postolachi to the 80th anniversary since the birth

2021-10-18T09:10:22Z

Illarion Postolachi to the 80th anniversary since the birth Postolachi, Alexander

Osteochondrosis: pathogenetic bioregulatory opportunities of using Discus compositum

2021-10-18T10:45:29Z

Osteochondrosis: pathogenetic bioregulatory opportunities of using Discus compositum Martynchuk, Alexandr A.; Popovych, Sergei V. Background: Osteochondrosis is a degenerative-dystrophic disc disease, characterized by a primary lesion of the intervertebral disc cartilage and reactive changes of the adjacent vertebral bodies. As a result of deterioration in metabolic processes in the intervertebral discs there occur in them degenerative-dystrophic processes, which lead to reduction in hydrophilicity and degradation of their dampening properties. There occurs the thinning of the fibrous ring, it cracks, and the displacement of the nucleus pulposus occurs, forming an outpouching- protrusion, and at rupture of the fibrous ring – the hernia. The affection of the intervertebral disc occurs due to its repeated injuries, metabolic disorders, endocrine changes, inadequate and protracted reactions of vascular, musculoskeletal and endocrine systems to stress. In osteochondrosis and accompanying pain syndromes, a wide range of drugs is applied: nonsteroidal anti-inflammatory drugs, analgesics, anesthetics, agents that enhance blood circulation, osteotropic agents, neuromuscular relaxants, etc. However, these groups of drugs have mainly temporary symptomatic effects and do not provide the necessary pathogenetic therapy. Conclusions: Discus compositum is a base complex bioregulatory drug for the treatment of osteochondrosis and its complications. It acts on the main substrate of osteochondrosis, contributing to the improvement of the elastic properties of hydrophilicity of intervertebral discs. Discus compositum is well tolerated, including by children, and does not cause side effects characteristic for nonsteroidal anti-inflammatory drugs. It is used both as a monotherapy and in combination with other complex bioregulatory drugs and traditional medicines, thereby increasing the effectiveness of treatment, reducing its duration, avoiding surgery.

Study of carotid artery changes in patients with ischemic stroke and metabolic syndrome

2021-10-18T10:47:33Z

Study of carotid artery changes in patients with ischemic stroke and metabolic syndrome Ciobanu, Natalia; Groppa, Stanislav Background: The metabolic syndrome is a major and escalating public-health problem and a clinical challenge worldwide. The increasing prevalence of metabolic syndrome is associated with heart and cerebrovascular diseases. Material and methods: A “case-control” study was performed on 125 subjects that were examined in the Cerebrovascular Diseases Neurology Department of the Emergency Medicine Institute, in the period of March 2015–July 2015. All subjects underwent a complete clinical examination and ultrasound examination of the extracranial carotids. Results: The present study shows that the patients with metabolic syndrome (MS) have values of the intima-media thickness and the internal diameter of the common carotid artery significantly higher than the subjects without the metabolic syndrome (p <0.05). Regarding the relationship between the number of risk factors and the markers of atherosclerotic carotid damage, a strong dependence between the two parameters was observed. Thus, it can be stated that 74% of the IMT variation and 77% of the luminal diameter variation is explained by the variation of the number of risk factors constituting MS. Conclusions: The obtained results, suggest that the cluster of risk factors, the MS constituents are connected with the alteration of the carotid arteries, these changes explain the relationship between the MS and the high risk of heart and cerebrovascular pathologies. In MS the risk of cerebrovascular diseases is multifactorial and its early detection and its treatment can prevent vascular events.